Literature DB >> 17582573

From rabbits to humans: the contributions of Dr. Theodore E. Woodward to tularemia research.

Alan S Cross1, Frank M Calia, Robert Edelman.   

Abstract

Tularemia is an endemic zoonotic infection caused by Francisella tularensis, which primarily causes infection in humans who have handled contaminated animal tissue or have been bitten by infected arthropods. Because of its ease of dispersion and transmission and its high degree of infectivity, F. tularensis is also considered to be a bioterrorism agent. Consequently, there is renewed interest in the development of safe, effective measures, such as vaccines, to prevent the morbidity and mortality associated with aerosol exposure to F. tularensis. Current efforts, however, are hampered by the lack of an animal model that faithfully reproduces human infection. Employing a model of "induced human infection" with aerosol administration of F. tularensis, Dr. Theodore E. Woodward and colleagues pioneered the clinical studies of tularemia vaccines that form the basis for current tularemia vaccine research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17582573     DOI: 10.1086/518150

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling.

Authors:  Leah E Cole; Michelle H W Laird; Anna Seekatz; Araceli Santiago; Zhaozhao Jiang; Eileen Barry; Kari Ann Shirey; Katherine A Fitzgerald; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

2.  Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.

Authors:  Mark J Mulligan; Jack T Stapleton; Wendy A Keitel; Sharon E Frey; Wilbur H Chen; Nadine Rouphael; Srilatha Edupuganti; Allison Beck; Patricia L Winokur; Hana M El Sahly; Shital M Patel; Robert L Atmar; Irene Graham; Edwin Anderson; Samer S El-Kamary; Marcela F Pasetti; Marcelo B Sztein; Heather Hill; Johannes B Goll
Journal:  Vaccine       Date:  2017-07-24       Impact factor: 3.641

3.  Establishment of three Francisella infections in zebrafish embryos at different temperatures.

Authors:  Espen Brudal; Lilia S Ulanova; Elisabeth O Lampe; Anne-Lise Rishovd; Gareth Griffiths; Hanne C Winther-Larsen
Journal:  Infect Immun       Date:  2014-03-10       Impact factor: 3.441

4.  Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis.

Authors:  Michael A Apicella; Deborah M B Post; Andrew C Fowler; Bradley D Jones; Jed A Rasmussen; Jason R Hunt; Sayaka Imagawa; Biswa Choudhury; Thomas J Inzana; Tamara M Maier; Dara W Frank; Thomas C Zahrt; Kathryn Chaloner; Michael P Jennings; Molly K McLendon; Bradford W Gibson
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

Review 5.  Live attenuated tularemia vaccines: recent developments and future goals.

Authors:  Mark E Marohn; Eileen M Barry
Journal:  Vaccine       Date:  2013-06-10       Impact factor: 3.641

6.  Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes.

Authors:  Araceli E Santiago; Leah E Cole; Augusto Franco; Stefanie N Vogel; Myron M Levine; Eileen M Barry
Journal:  Vaccine       Date:  2009-03-03       Impact factor: 3.641

7.  An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes.

Authors:  Marcela F Pasetti; Lilian Cuberos; Thomas L Horn; Jeffry D Shearer; Stephen J Matthews; Robert V House; Marcelo B Sztein
Journal:  Vaccine       Date:  2008-01-29       Impact factor: 3.641

8.  Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses.

Authors:  Muktha S Natrajan; Nadine Rouphael; Lilin Lai; Dmitri Kazmin; Travis L Jensen; David S Weiss; Chris Ibegbu; Marcelo B Sztein; William F Hooper; Heather Hill; Evan J Anderson; Robert Johnson; Patrick Sanz; Bali Pulendran; Johannes B Goll; Mark J Mulligan
Journal:  Vaccines (Basel)       Date:  2019-12-24

9.  Retrospective Analysis of Pneumonic Tularemia in Operation Whitecoat Human Subjects: Disease Progression and Tetracycline Efficacy.

Authors:  Mark S Williams; Marianne R Baker; Tina Guina; Judith A Hewitt; Lynda Lanning; Heather Hill; Jeanine M May; Beverly Fogtman; Phillip R Pittman
Journal:  Front Med (Lausanne)       Date:  2019-10-22

10.  A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.

Authors:  Roger D Pechous; Travis R McCarthy; Nrusingh P Mohapatra; Shilpa Soni; Renee M Penoske; Nita H Salzman; Dara W Frank; John S Gunn; Thomas C Zahrt
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.